Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug

World Journal of Gastroenterology

Volumn 11, Issue 7, 2005, Pages 1040-1043

  Hagiwara, Mari ^a   Kataoka, Keiko ^a   Arimochi, Hideki ^a   Kuwahara, Tomomi ^a   Nakayama, Haruyuki ^a   Ohnishi, Yoshinari ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Fluvastatin; HMG CoA reductase inhibitors; Ileal ulcer; Nonsteroidal antiinflammatory drug

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ILEUM DISEASE; INTESTINE ULCER; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOICHIOMETRY;

EID: 14844327983     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i7.1040     Document Type: Article

References (31)

1. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ. Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480-489
2. Langman MJ. Epidemiologic evidence on the assocation between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989; 96: 640-646
3. Pemberton RE, Strand LJ. A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents. Dig Dis Sci 1979; 24: 53-64
4. Rainsford KD. An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 1982; 2: 1-10
5. Sun DC, Roth SH, Mitchell CS, Englund DW. Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis 1974; 19: 405-410
6. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-754
7. Deakin M. Small bowel perforation associated with an excessive dose of slow release diclofenac sodium. Br Med J 1988; 297: 488-489
8. Langman MJ, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and hemorrhage. Br Med J 1985; 290: 347-349
9. Beck WS, Schneider HT, Dietzel K, Neurnberg B, Brune K. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats: Physicochemical and biochemical factors involved. Arch Toxicol 1990; 64: 210-217
10. Uejima M, Kinouchi T, Kataoka K, Hiraoka I, Ohnishi Y. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal an antiinflammatory drug. Microbiol Immunol 1996; 40: 553-560
11. Bjarnason I, Hayllar J, Macpherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847
12. Rainsford KD. Mechanisms of gastrointestinal toxicity of non-steoridal anti-inflammatory drugs. Scand J Gastroenterol Suppl 1989; 163: 9-16
13. Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJS, Bjarnason I. The biochemical basis of nonsteroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and hypothesis. Scand J Gastroenterol 1995; 30: 289-299
14. Brzozowski T, Kwiecien S, Konturek P, Konturek SJ, Mitis-Musiol M, Duda A, Bielanski W, Hahn E. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; Involvement of reactive oxygen species. Med Sci Monit 2001; 7: 592-599
15. Hassan A, Martin E, Puig-Parellada P. Role of antioxidants in gastric mucosal damage induced by indomethacin in rats. Methods Find Exp Clin Pharmacol 1998; 20: 849-854
16. Naito Y, Yoshikawa T, Yoshida N, Kondo M. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci 1998; 43: 30S-34S
17. Gans KR, Galbraith W, Roman RJ, Haber SB, Kerr JS, Schmidt WK, Smith C, Hewes WE, Ackerman NR. Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J Pharmacol Exp Ther 1990; 254: 180-187
18. Kinouchi T, Kataoka K, Shan RB, Nakayama H, Uejima M, Shimono K, Kuwahara T, Akimoto S, Hiraoka I, Ohnishi Y. Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation. Microbiol Immunol 1998; 42: 347-355
19. Shan RB, Kinouchi T, Kataoka K, Kuwahara T, Ohnishi Y. Protective effects of a culture supernatant of Lactobacillus acidophilus and antioxidants on ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol 1998; 42: 745-753
20. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
22. Suzumura K, Tanaka K, Yasuhara M, Narita H. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein. Biol Pharm Bull 2000; 23: 873-878
23. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP Assay. Anal Biochem 1996; 239: 70-76
24. Higashimoto M, Akada Y, Sato M, Yamada Y, Kuwahara T, Ohnishi Y. Inhibitory effects of herbal teas and herb extracts on the mutagenicity of 1-methyl-1, 2, 3, 4-tetrahydro-β-carboline-3-carboxylic acid upon treatment with nitrite in the presence of ethanol. Environ Mutagen Res 2001; 23: 1-7
25. Lau OW, Luk SF, Huang HL. Spectrophotometric determination of tannins in tea and beer samples with iron (III) and 1, 10-phenanthroline as reagents. Analyst 1989; 114: 631-633
26. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259(3 Pt 1): G462-G467
27. Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S, Ichikawa H, Yasuda M, Takahashi S, Kondo M. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993; 34: 732-737
28. Kanno T, Abe K, Yabuki M, Akiyama J, Yasuda T, Horton AA. Selective inhibition of formyl-methionyl-leucyl-phenylalanine (fMLF)-dependent superoxide generation in neutrophils by pravastatin, an inhibitor of 3-hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) reductase. Biochem Pharmacol 1999; 58: 1975-1980
29. Suzumura K, Yasuhara M, Tanaka K, Odawara A, Narita H, Suzuki T. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, an HMG-CoA reductase inhibitor. Chem Pharm Bull 1999; 47: 1010-1012
30. Suzumura K, Yasuhara M, Narita H. Superoxide anion scavenging properties of fluvastatin and its metabolites. Chem Pharm Bull 1999; 47: 1477-1480
31. Yamamoto A, Hoshi K, Ichihara K. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes. Eur J Pharmacol 1998; 361: 143-149